Gevitha Ananthavettivelu

Gevitha Ananthavettivelu has a diverse work experience spanning multiple roles and companies. Gevitha started their career as a Student Associate at Paul-Ehrlich-Institut in 2013 and later moved on to the Institute of Neurology (Edinger Institute) in 2014, where they worked as a Student Associate until 2016. Gevitha then joined Universitätsklinikum Hamburg Eppendorf as a Doctoral Student from April 2016 to June 2020. Following that, they worked at Spiden as a Clinical Chemist intern from June 2021 to September 2021, then as a Clinical Junior Scientist from September 2021 to March 2023. Currently, they hold the role of Clinical Scientist - Clinical Study Coordinator at Spiden since April 2023.

Gevitha Ananthavettivelu started their education journey in 2010 at Goethe University Frankfurt, where they pursued a Bachelor's degree in Biochemistry. Gevitha completed this program in 2013. Subsequently, they enrolled at the same university and pursued a Master's degree in Molecular Medicine from 2013 to 2016. Building upon their academic pursuits, Gevitha went on to join the University of Hamburg in 2016 to pursue a Doctor of Philosophy (PhD) degree in Biology with a specialization in Immunology. Gevitha successfully completed their doctoral program in 2020.